Form 4: Corbus Pharmaceuticals Director Alan Holmer Receives Stock Units
SEC Form 4 Filing
Director Alan Holmer received 2,783 restricted stock units in Corbus Pharmaceuticals Holdings, Inc. on May 30, 2024, which will vest in one year.
Summary
- Alan Holmer, a director of Corbus Pharmaceuticals Holdings, Inc., was granted 2,783 restricted stock units (RSUs) on May 30, 2024.
- These RSUs will be settled in shares of common stock with a par value of $0.0001.
- The RSUs will vest 100% on the one-year anniversary of the grant date.
- Following the transaction, Holmer beneficially owns 4,162 shares, including the unvested RSUs.
Sentiment
Score: 6
Explanation: The document itself is neutral, simply reporting a transaction. The grant of RSUs can be seen as a positive sign of aligning director interests with shareholders, but it's not a major event.
Positives
- The grant of RSUs to a director aligns their interests with those of the shareholders.
- The vesting period encourages long-term commitment from the director.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance, but the RSU grant suggests an expectation of continued service from the director.
Industry Context
Stock grants and RSU awards are common practices in the pharmaceutical industry to incentivize and retain key personnel, aligning their interests with the company's long-term success.
Comparison to Industry Standards
- RSU grants are a standard form of compensation for directors in publicly traded companies, particularly in the biotech and pharmaceutical sectors.
- The vesting schedule of one year is fairly typical for RSU grants.
- Comparable companies like BioNTech or Moderna also utilize stock-based compensation for their directors and executives.
Stakeholder Impact
- The RSU grant could have a slightly positive impact on shareholder sentiment as it aligns the director's interests with the company's performance.
- Employees may view the RSU grant as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 2024/03/08 | Date of Power of Attorney execution. |
| 05/30/2024 | Date of RSU grant: 2,783 restricted stock units granted to Alan Holmer. |
| 05/30/2025 | RSUs will vest 100% on the one-year anniversary from the date of grant. |
| 06/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.